This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lembo, D.
Right arrow Articles by Landolfo, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lembo, D.
Right arrow Articles by Landolfo, S.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, April 2008, p. 1374-1381, Vol. 52, No. 4
0066-4804/08/$08.00+0     doi:10.1128/AAC.01467-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Sulfated K5 Escherichia coli Polysaccharide Derivatives as Wide-Range Inhibitors of Genital Types of Human Papillomavirus{triangledown}

David Lembo,1* Manuela Donalisio,1 Marco Rusnati,2 Antonella Bugatti,2 Maura Cornaglia,1 Paola Cappello,3 Mirella Giovarelli,3 Pasqua Oreste,4 and Santo Landolfo5

Department of Clinical and Biological Sciences, University of Turin, San Luigi Gonzaga Hospital, 10043 Orbassano, Turin, Italy,1 Department of Biomedical Sciences and Biotechnology, University of Brescia, 25123 Brescia, Italy,2 Department of Medicine and Experimental Oncology, University of Turin, and Center for Experimental Research and Medical Studies, San Giovanni Battista Hospital, 10126 Turin, Italy,3 Glycores 2000 Srl, 20155 Milan, Italy,4 Department of Public Health and Microbiology, University of Turin, 10126 Turin, Italy5

Received 13 November 2007/ Returned for modification 22 December 2007/ Accepted 28 January 2008

Genital human papillomaviruses (HPV) represent the most common sexually transmitted agents and are classified into low or high risk by their propensity to cause genital warts or cervical cancer, respectively. Topical microbicides against HPV may be a useful adjunct to the newly licensed HPV vaccine. A main objective in the development of novel microbicides is to block HPV entry into epithelial cells through cell surface heparan sulfate proteoglycans. In this study, selective chemical modification of the Escherichia coli K5 capsular polysaccharide was integrated with innovative biochemical and biological assays to prepare a collection of sulfated K5 derivatives with a backbone structure resembling the heparin/heparan biosynthetic precursor and to test them for their anti-HPV activity. Surface plasmon resonance assays revealed that O-sulfated K5 with a high degree of sulfation [K5-OS(H)] and N,O-sulfated K5 with a high [K5-N,OS(H)] or low [K5-N,OS(L)] sulfation degree, but not unmodified K5, N-sulfated K5, and O-sulfated K5 with low levels of sulfation, prevented the interaction between HPV-16 pseudovirions and immobilized heparin. In cell-based assays, K5-OS(H), K5-N,OS(H), and K5-N,OS(L) inhibited HPV-16, HPV-18, and HPV-6 pseudovirion infection. Their 50% inhibitory concentration was between 0.1 and 0.9 µg/ml, without evidence of cytotoxicity. These findings provide insights into the design of novel, safe, and broad-spectrum microbicides against genital HPV infections.

* Corresponding author. Mailing address: Department of Clinical and Biological Sciences, University of Turin, San Luigi Gonzaga Hospital, Regione Gonzole 10, 10043 Orbassano, Turin, Italy. Phone: 39 011 6705484. Fax: 39 011 2365484. E-mail: david.lembo{at}unito.it

{triangledown} Published ahead of print on 4 February 2008.

Antimicrobial Agents and Chemotherapy, April 2008, p. 1374-1381, Vol. 52, No. 4
0066-4804/08/$08.00+0     doi:10.1128/AAC.01467-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Pinna, D., Oreste, P., Coradin, T., Kajaste-Rudnitski, A., Ghezzi, S., Zoppetti, G., Rotola, A., Argnani, R., Poli, G., Manservigi, R., Vicenzi, E. (2008). Inhibition of Herpes Simplex Virus Types 1 and 2 In Vitro Infection by Sulfated Derivatives of Escherichia coli K5 Polysaccharide. Antimicrob. Agents Chemother. 52: 3078-3084 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»